The Future of Warfare Is Drones. This Defense Stock Is Perfectly Positioned to Benefit.

Kraken Robotics posted 60% YoY revenue growth to CAD 31 million in Q3 2025 and secured large subsea battery orders (CAD 24M in March, CAD 35M in January). It announced a CAD 615M acquisition of Colvya Group, creating combined 2025 revenue of CAD 365M while Kraken had a pre-merger market cap of ~CAD 2.1B and raised hundreds of millions via a stock offering (share dilution). The piece highlights strong defense-driven demand after the Strait of Hormuz disruption but warns the stock is expensive and risky despite a long runway for growth.

Analysis

A sustained re‑rating of subsea autonomy will be driven more by qualification and supply‑chain control than by single contract announcements. Subsea batteries require pressure‑tolerant cell chemistries, bespoke BMS/hardware sealing and NAV/EMC certification cycles that typically take 12–36 months per navy procurement; a supplier that controls those technical gates can command structural gross‑margins but also faces long lead times to ramp revenue.

The near‑term balance sheet and execution story matters as much as the product roadmap. Equity‑financed M&A and capacity expansion compress EBITDA in the 0–24 month window and introduce delivery risk: tooling, potting compounds, titanium housings and qualified cell supply lines have 6–18 month lead times, so missed supplier qualifications or a single OEM concentration loss would quickly reverse the growth narrative. Conversely, export controls/ITAR‑style regimes can be a moat if the company is already certified for sensitive defense builds.

For investors, the payoff profile is asymmetric but binary: 2–5x upside if multi‑year framework agreements and successful Colvya integration convert to repeatable, high‑margin book‑and‑turn; 60–100% downside if dilution, certification failures or a geopolitical détente slow procurement. Key catalysts to watch are multi‑year contract wins, third‑party cell qualification milestones, FTA/ITAR filings and quarterly manufacturing cadence over the next 6–24 months.

Key Decisions for Investors

• Tactical asymmetric long (KRKNF): allocate 1–2% NAV via a 24–36 month call‑spread (buy long‑dated ATM calls, sell higher‑strike calls to fund) to capture 3x+ upside if multi‑year framework contracts scale. Max loss = premium paid; target take‑profit 200–300% on spread value within 18–36 months.
• Risk‑limited equity hedge for holders: if owning KRKNF shares, buy 12‑month puts 20–30% OTM sized to cover 50–75% of position to protect against dilution/certification setbacks; acceptable cost = ~5–15% of position value for insurance versus a potential 60–100% downside.
• Relative, liquid exposure to defense/autonomy: prefer NVDA calls (12–24 months) over large direct equity exposure to KRKNF for core allocations — NVDA offers scalable, liquid optionality to AI/autonomy tailwinds with lower idiosyncratic execution risk. Position size 3–5% NAV with 20–35% IRR target, stop‑loss at 30% drawdown.
• Event‑driven sizing rules: use contract award and cell‑qualification milestones to scale into KRKNF (add on verified multi‑year frameworks; trim on any announced financing >10% issuance or missed supplier qualifications). Set alerts for quarterly manufacturing run‑rates and regulatory/ITAR filings over the next 6–24 months.